Mitigation of radiation-induced lung injury with EUK-207 and genistein: Effects in adolescent rats

Radiation Research

Volumn 179, Issue 2, 2013, Pages 125-134

  Mahmood, J ^a   Jelveh, S ^a   Zaidi, A ^a   Doctrow, S R ^b   Hill, R P ^c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; EUK 207; GENISTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING RATE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IRRADIATION; LIVER FIBROSIS; LUNG INJURY; MACROPHAGE ACTIVATION; MORBIDITY; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; RAT;

AGE FACTORS; ANIMALS; CYTOKINES; FEMALE; FIBROSIS; GENISTEIN; LUNG; LUNG INJURY; MACROPHAGES; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RESPIRATION;

EID: 84874100920     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2954.1     Document Type: Article

References (58)

1. Hamada N, Ogino H. Food safety regulations: what we learned from the Fukushima nuclear accident. J Environ Radioact 2012;111:83-99
2. Drouet M, Herodin F. Radiation victim management and the haematologist in the future: time to revisit therapeutic guidelines? Int J Radiat Biol 2010; 86(8):636-48.
3. Vlasov PA, Kvacheva Iu E. The pathomorphology of the pulmonary infectious complications in acute radiation sickness based on the autopsy data from persons who died as a result of the accident at the Chernobyl Atomic Electric Power Station. Ter Arkh 1996; 68(3):23-6.
4. Goans RE, Wald N. Radiation accidents with multi-organ failure in the United States. BJR Suppl 2005; 27:41-6.
5. Hirama T, Akashi M. Multi-organ involvement in the patient who survived the Tokai-mura criticality accident. BJR Suppl 2005; 27:17-20.
6. Svendsen ER, Kolpakov IE, Stepanova YI, Vdovenko VY, Naboka MV, Mousseau TA, et al. 137Cesium exposure and spirometry measures in Ukrainian children affected by the Chernobyl nuclear incident. Environ Health Perspect 2010; 118(5):720-5.
7. Uozaki H, Fukayama M, Nakagawa K, Ishikawa T, Misawa S, Doi M, et al. The pathology of multi-organ involvement: two autopsy cases from the Tokai-mura criticality accident. BJR 2005; 27:13-6.
8. Kim K, Pollard JM, Norris AJ, McDonald JT, Sun Y, Micewicz E, et al. High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clin Cancer Res 2009; 15(23):7238-45.
9. Moulder JE, Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol 2007; 17(2):141-8.
10. Williams JP, Johnston CJ, Finkelstein JN. Treatment for radiationinduced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets 2010; 11(11):1386-94.
11. Xiao M, Whitnall MH. Pharmacological countermeasures for the acute radiation syndrome. Curr Mol Pharmacol 2009; 2(1):122-33.
12. Zhao W, Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 2009; 16(2):130-43.
13. Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999; 17(10):3333-55.
14. Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res 2004; 162(6):711-28.
15. Day RM, Barshishat-Kupper M, Mog SR, McCart EA, Prasanna PG, Davis TA, et al. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. J Radiat Res (Tokyo) 2008; 49(4):361-72.
16. Calveley VL, Jelveh S, Langan A, Mahmood J, Yeung IW, Van Dyk J, et al. Genistein can mitigate the effect of radiation on rat lung tissue. Radiat Res 2010; 173(5):602-11.
17. Mahmood J, Jelveh S, Calveley V, Zaidi A, Doctrow SR, Hill RP. Mitigation of radiation-induced lung injury by Genistein and EUK-207. Int J Radiat Biol 2011; 87(8):889-901.
18. Mahmood J, Jelveh S, Calveley V, Zaidi A, Doctrow SR, Hill RP. Mitigation of lung injury after accidental exposure to radiation. Radiat Res 2011; 176(6):770-80.
19. Zhang HJ, Doctrow SR, Xu L, Oberley LW, Beecher B, Morrison J, et al. Redox modulation of the liver with chronic antioxidant enzyme mimetic treatment prevents age-related oxidative damage associated with environmental stress. Faseb J 2004; 18(13): 1547-9.
20. Clausen A, Doctrow S, Baudry M. Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase/catalase mimetics in aged mice. Neurobiol Aging 2010; 31(3):425-33.
21. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262(12):5592-5.
22. Baxa DM, Yoshimura FK. Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha. Biochem Pharmacol 2003; 66(6):1009-18.
23. Choi C, Cho H, Park J, Cho C, Song Y. Suppressive effects of genistein on oxidative stress and NFkappaB activation in RAW 264.7 macrophages. Biosci Biotechnol Biochem 2003; 67(9): 1916-22.
24. Michael McClain R, Wolz E, Davidovich A, Pfannkuch F, Edwards JA, Bausch J. Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 2006; 44(1): 56-80.
25. Langan AR, Khan MA, Yeung IW, Van Dyk J, Hill RP. Partial volume rat lung irradiation: the protective/mitigating effects of Eukarion-189, a superoxide dismutase-catalase mimetic. Radiother Oncol 2006; 79(2):231-8.
26. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A 2003; 100(14):8526-31.
27. Peng J, Stevenson FF, Doctrow SR, Andersen JK. Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease. J Biol Chem 2005; 280(32):29194-8.
28. Rosenthal RA, Huffman KD, Fisette LW, Damphousse CA, Callaway WB, Malfroy B, et al. Orally available Mn porphyrins with superoxide dismutase and catalase activities. J Biol Inorg Chem 2009; 14(6):979-91.
29. Vorotnikova E, Rosenthal RA, Tries M, Doctrow SR, Braunhut SJ. Novel synthetic SOD/catalase mimetics can mitigate capillary endothelial cell apoptosis caused by ionizing radiation. Radiat Res 2010; 173(6):748-59.
30. Williams JP, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, Dicarlo AL. Animal models and medical countermeasures development for radiation-induced lung damage: report from an NIAID workshop. Radiat Res 2012; 177(5):e0025-39.
31. Trezza V, Campolongo P, Vanderschuren LJ. Evaluating the rewarding nature of social interactions in laboratory animals. Dev Cogn Neurosci 2011; 1(4):444-58.
32. Kaneko T, Tahara S, Tanno M, Taguchi T. Effect of age on the induction of 8-oxo-20-deoxyguanosine-releasing enzyme in rat liver by gamma-ray irradiation. Arch Gerontol Geriatr 2003; 36(1): 23-35.
33. Malfroy-Camine B, Doctrow S. Cyclic salen Mn compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of disease. U.S. Patent Number 7, 123, 527. 2006.
34. Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmood J, et al. Salen Mn complexes mitigate radiation injury in normal tissues. Anticancer Agents Med Chem 2011; 11(4): 359-72.
35. Clarkson R, Lindsay PE, Ansell S, Wilson G, Jelveh S, Hill RP, et al. Characterization of image quality and image-guidance performance of a preclinical microirradiator. Med Phys 2011; 38(2): 845-56.
36. Fleckenstein K, Gauter-Fleckenstein B, Jackson IL, Rabbani Z, Anscher M, Vujaskovic Z. Using biological markers to predict risk of radiation injury. Semin Radiat Oncol 2007; 17(2):89-98.
37. Robbins ME, Zhao W. Chronic oxidative stress and radiationinduced late normal tissue injury: A review. Int J Radiat Biol 2004; 80(4):251-9.
38. van Eerde MR, Kampinga HH, Szabo BG, Vujaskovic Z. Comparison of three rat strains for development of radiationinduced lung injury after hemithoracic irradiation. Radiother Oncol 2001; 58(3):313-6.
39. Rabbani ZN, Batinic-Haberle I, Anscher MS, Huang J, Day BJ, Alexander E, et al. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int J Radiat Oncol Biol Phys 2007; 67(2):573-80.
40. Gauter-Fleckenstein B, Fleckenstein K, Owzar K, Jiang C, Reboucas JS, Batinic-Haberle I, et al. Early and late administration of MnTE-2-PyP5 in mitigation and treatment of radiationinduced lung damage. Free Radic Biol Med 2010; 48(8):1034-43.
41. Siemann DW, Sutherland RM. A comparison of the pharmacokinetics of multiple and single dose administrations of adriamycin. Int J Radiat Oncol Biol Phys 1979; 5(8):1271-4.
42. Travis EL, Bucci L, Fang MZ. Residual damage in mouse lungs at long intervals after cyclophosphamide treatment. Cancer Res 1990; 50(7):2139-45.
43. van den Aardweg GJ, Olofsen-van Acht MJ, van Hooije CM, Levendag PC. Radiation-induced rectal complications are not influenced by age: A dose fractionation study in the rat. Radiat Res 2003; 159(5):642-50.
44. Diao RY, Song LW, Wang SX, Li M. Biological effect of (60)Cogamma ray on alveolar type II cells and interstitial cells of alveoliar septum in radiation pulmonary injury. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (Chin J Cell Mol Immun) 2008; 24(2): 119-21.
45. Osterreicher J, Pejchal J, Skopek J, Mokry J, Vilasova Z, Psutka J, et al. Role of type II pneumocytes in pathogenesis of radiation pneumonitis: dose response of radiation-induced lung changes in the transient high vascular permeability period. Exp Toxicol Pathol 2004; 6(3):181-7.
46. Ryu SY, Do SH, Chung JY, Kim TH, Kim SH, Choi CY, et al. Activation of MAP kinases during progression of radiationinduced pneumonitis in rats. Hum Exp Toxicol 2010; 30(8): 876-83.
47. Travis EL. Organizational response of normal tissues to irradiation. Semin Radiat Oncol 2001; 11(3):184-96.
48. Krasin MJ, Constine LS, Friedman DL, Marks LB. Radiationrelated treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other. Semin Radiat Oncol 2010; 20(1):21-9.
49. Magee PJ, McGlynn H, Rowland IR. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 2004; 208(1):35-41.
50. Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB, Chambers AF. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res 2005; 65(8): 3396-403.
51. Farina HG, Pomies M, Alonso DF, Gomez DE. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 2006; 16(4): 885-91.
52. Singh AV, Franke AA, Blackburn GL, Zhou JR. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 2006; 66(3):1851-8.
53. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, et al. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 2008; 68(6):2024-32.
54. Chambers AF. Influence of diet on metastasis and tumor dormancy. Clin Exp Metastasis 2009; 26(1):61-6.
55. El Touny LH, Banerjee PP. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res 2009; 69(8):3695-703.
56. Martinez-Montemayor MM, Otero-Franqui E, Martinez J, De La Mota-Peynado A, Cubano LA, Dharmawardhane S. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression. Clin Exp Metastasis 2010; 27(7):465-80.
57. Nakamura H, Wang Y, Kurita T, Adomat H, Cunha GR, Wang Y. Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer. PLoS One 2011; 6(5):e20034.
58. Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, et al. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer 2010; 62(7):996-1000.